Brief: Virpax Pharmaceuticals to Utilize Dr Singla to Assist in Development of Probudur
18/01/2023 14:06
Jan 18 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS TO UTILIZE DR. NEIL K. SINGLA TO
ASSIST
IN DEVELOPMENT OF PROBUDUR™
Source text for Eikon: ID:nBw8lwfcWa
Further company coverage: VRPX.O
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study